28 De Blok proposed that hormonal therapy in transgender women is usually a fixed dose, unlike hormone fluctuations seen with cisgender females (i.e. puberty, menstrual cycle, pregnancy), contributing to a lower overall prevalence of fibroadenomas in this patient population.28 The mammographic, ...